Urologic oncology patient perspectives during COVID-19 treatment delays.

Faris, Anna; Herrel, Lindsey; Montie, James E; Chisolm, Stephanie; Duby, Ashley; Wittmann, Daniela

Faris, Anna; Herrel, Lindsey; Montie, James E; Chisolm, Stephanie; Duby, Ashley; Wittmann, Daniela.

Afiliação

Faris A; Department of Urology, University of Michigan, Ann Arbor, MI, USA. fariasan@med.umich.edu.
Herrel L; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
Montie JE; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
Chisolm S; Bladder Cancer Advocacy Network (BCAN), Bethesda, MD, USA.
Duby A; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
Wittmann D; Department of Urology, University of Michigan, Ann Arbor, MI, USA.

Support Care Cancer ; 30(8): 7015-7020, 2022 Aug.

Article em En | MEDLINE | ID: mdl-35583826

Assuntos

Tratamento Farmacológico da COVID-19; Neoplasias Urológicas; Feminino; Humanos; Masculino; Oncologia; Pandemias; Neoplasias Urológicas/terapia

Palavras-chave

COVID-19; Cancer patients; Distress; Stress; Treatment delay

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Urológicas / Tratamento Farmacológico da COVID-19 Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google